Literature DB >> 7802059

Adnexal torsion: can the adnexa be saved?

A I Bayer1, A K Wiskind.   

Abstract

OBJECTIVE: Our purpose was to identify which cases of adnexal torsion may be managed with adnexal conservation. STUDY
DESIGN: A retrospective chart review was conducted on all patients diagnosed with adnexal torsion between February 1983 and February 1993 at four hospitals in the Emory University system.
RESULTS: Fifty-nine patients ranging in age from 23 months to 73 years (mean 31.9 years) were reviewed. Almost half of the patients were nulliparous. Lower abdominal pain (83%) and an adnexal mass (72%) were the most common presenting findings, but in general clinical findings were nonspecific. Most patients were treated with extirpative therapy of the affected adnexa. Untwisting of the adnexa was performed in 10 patients; however, adnexal conservation was accomplished in only one patient. There were no thromboembolic complications in any of the patients.
CONCLUSIONS: Adnexal torsion is a diagnostic challenge, often with nonspecific symptoms. There is growing evidence that untwisting the involved adnexa to observe for tissue reperfusion and viability is safe. However, significant delay in surgical intervention may result in irreversible tissue necrosis, rendering the adnexa unsalvageable.

Entities:  

Mesh:

Year:  1994        PMID: 7802059     DOI: 10.1016/0002-9378(94)90393-x

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  13 in total

1.  Simultaneous bilateral torsion of the adnexae in an adult female without any history of ovarian stimulation.

Authors:  Kula Abdusamad; Raied Hamoudi; S Maiti
Journal:  BMJ Case Rep       Date:  2013-01-30

2.  Clinico-pathological profile of adnexal torsion cases: a retrospective analysis from a tertiary care teaching hospital.

Authors:  Kandasamy Vijayalakshmi; Gopireddy Murali Mohan Reddy; Vasantha Nagamma Subbiah; Saktivel Sathiya; Balasubramanian Arjun
Journal:  J Clin Diagn Res       Date:  2014-06-20

3.  Association between peak estradiol levels and ovarian torsion among symptomatic patients receiving gonadotropin treatment.

Authors:  Phillip A Romanski; Alexander Melamed; Kevin M Elias; Aleksandar K Stanic; Raymond M Anchan
Journal:  J Assist Reprod Genet       Date:  2017-03-15       Impact factor: 3.412

4.  A Missed Diagnosis of Ovarian Torsion in a Patient with Bilateral Ovarian Dermoid Cysts: A Case Report.

Authors:  Agrima Ghosh; Rebecca McKay
Journal:  Cureus       Date:  2019-10-22

5.  Ischemia-reperfusion injury of rabbit ovary and protective effect of trapidil: an experimental study.

Authors:  Salih Somuncu; Murat Cakmak; Gunnur Dikmen; Hülya Akman; Murat Kaya
Journal:  Pediatr Surg Int       Date:  2007-11-30       Impact factor: 1.827

6.  Does gradual detorsion protect the ovary against ischemia-reperfusion injury in rats?

Authors:  Sezen Ozkisacik; Mesut Yazici; Harun Gursoy; Nil Culhaci
Journal:  Pediatr Surg Int       Date:  2014-02-12       Impact factor: 1.827

7.  Torsion of a normal ovary in the third trimester of pregnancy: a case report.

Authors:  Arumugam Silja; Vaidyanathan Gowri
Journal:  J Med Case Rep       Date:  2008-12-08

8.  Conservative surgery for ovarian torsion in young women: perioperative complications and national trends.

Authors:  R S Mandelbaum; M B Smith; C J Violette; S Matsuzaki; K Matsushima; M Klar; L D Roman; R J Paulson; K Matsuo
Journal:  BJOG       Date:  2020-03-09       Impact factor: 6.531

9.  Comparison of ovarian torsion between pregnant and non-pregnant women at reproductive ages: sonographic and pathological findings.

Authors:  Jie-Ling Feng; Ju Zheng; Ting Lei; Yong-Jian Xu; Hui Pang; Hong-Ning Xie
Journal:  Quant Imaging Med Surg       Date:  2020-01

10.  Empty follicle syndrome associated with ovarian torsion in an in vitro fertilization program.

Authors:  Konstantinos Stefunidis; Michalis Grammatis; Kostas Pappas; Dimitris Haidopoulos; Kostas Chronopoulos; Kostas Pantos; Emmanuel Diakomanolis
Journal:  JSLS       Date:  2002 Jul-Sep       Impact factor: 2.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.